Literature DB >> 15096189

Autoreactive responses to an environmental factor. 2. Phthalate-induced anti-DNA specificity is downregulated by autoreactive cytotoxic T cells.

So-Yon Lim1, Swapan K Ghosh.   

Abstract

An environmental factor (phthalate) was shown, in our previous study, to induce serum anti-DNA responses in BALB/c, NZB and lupus-prone NZB/W F1 mice. Out of such anti-phthalate responses, cross-reactive populations were identified that strongly bind phthalate, DNA, or both. A phthalate-specific BALB/c monoclonal antibody, 2C3-Ig (gamma1,kappa), showed considerable affinity for DNA and had extensive sequence homology with the heavy and light chain variable regions of a known anti-DNA immunoglobulin, BV04-01, from lupus-prone NZB/W F1 mice. This study was initiated to address how BALB/c mice, but not NZB/W F1 mice, are protected from these adverse autoreactive B cells. Using 2C3 hybridoma cells as the prototype autoreactive BALB/c B cell, we determined whether its DNA-binding monoclonal antibody would induce any regulatory cell-mediated immune responses. Synthetic idiopeptides corresponding to the heavy and light chain variable regions of 2C3-Ig were found to be effective at inducing specific effector cells in BALB/c mice, but not in lupus-prone F1 mice. The splenocytes from BALB/c mice incubated in vitro with the idiopeptides, particularly the complementarity-determining region 1 (VL1) of the 2C3-Ig light chain, showed significant proliferative and cytolytic responses. A CD8+ cytotoxic T-lymphocyte (CTL) response was elicited that recognized the VL1 peptide presented by the Kd allele, and affected the growth of 2C3 cells. In vivo depletion of CD8+ T cells in BALB/c mice significantly decreased this CTL activity but increased the anti-DNA humoral response. These results suggest that autoreactive CTLs are induced in non-autoimmune prone mice as a mechanism to downregulate self-reactive B cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096189      PMCID: PMC1782471          DOI: 10.1111/j.1365-2567.2004.01842.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  46 in total

1.  Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides.

Authors:  J P Sauzet; H Gras-Masse; J G Guillet; E Gomard
Journal:  Int Immunol       Date:  1996-04       Impact factor: 4.823

Review 2.  The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset.

Authors:  A Saoudi; B Seddon; V Heath; D Fowell; D Mason
Journal:  Immunol Rev       Date:  1996-02       Impact factor: 12.988

Review 3.  Self-ignorance in the peripheral T-cell pool.

Authors:  J F Miller; W R Heath
Journal:  Immunol Rev       Date:  1993-06       Impact factor: 12.988

4.  Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2.

Authors:  H J Zeh; G H Leder; M T Lotze; R D Salter; M Tector; G Stuber; S Modrow; W J Storkus
Journal:  Hum Immunol       Date:  1994-02       Impact factor: 2.850

Review 5.  Tolerance, danger, and the extended family.

Authors:  P Matzinger
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Normal mice express idiotypes related to autoantibody idiotypes of lupus mice.

Authors:  S K Datta; B D Stollar; R S Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

7.  Expression and regulation of a recurrent anti-erythrocyte autoantibody idiotype in spleen cells from neonatal and adult BALB/c mice.

Authors:  R D Miller; M J Caulfield; C E Calkins
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

8.  Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.

Authors:  L W Kwak; H A Young; R W Pennington; S D Weeks
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle.

Authors:  L Mandik-Nayak; A Bui; H Noorchashm; A Eaton; J Erikson
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

10.  Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus.

Authors:  J H Roark; C L Kuntz; K A Nguyen; A J Caton; J Erikson
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Environmental Basis of Autoimmunity.

Authors:  Annarosa Floreani; Patrick S C Leung; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

2.  Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents.

Authors:  Glinda S Cooper; Joan Wither; Sasha Bernatsky; Jaime O Claudio; Ann Clarke; John D Rioux; Paul R Fortin
Journal:  Rheumatology (Oxford)       Date:  2010-07-31       Impact factor: 7.580

3.  Is lipstick associated with the development of systemic lupus erythematosus (SLE)?

Authors:  Jun Wang; Ashley B Kay; Jeremiah Fletcher; Margaret K Formica; Timothy E McAlindon
Journal:  Clin Rheumatol       Date:  2008-06-04       Impact factor: 2.980

4.  Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE.

Authors:  Mirjana Pavlovic; Anna Kats; Michelle Cavallo; Ran Chen; James X Hartmann; Yehuda Shoenfeld
Journal:  Autoimmune Dis       Date:  2010-07-20

5.  Immune enhancement by novel vaccine adjuvants in autoimmune-prone NZB/W F1 mice: relative efficacy and safety.

Authors:  Youssef Aachoui; Swapan K Ghosh
Journal:  BMC Immunol       Date:  2011-10-24       Impact factor: 3.615

6.  DNA methylation 101: what is important to know about DNA methylation and its role in SLE risk and disease heterogeneity.

Authors:  Cristina M Lanata; Sharon A Chung; Lindsey A Criswell
Journal:  Lupus Sci Med       Date:  2018-07-25

7.  Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses.

Authors:  So-Yon Lim; Matt Meyer; Richard A Kjonaas; Swapan K Ghosh
Journal:  J Immune Based Ther Vaccines       Date:  2006-10-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.